tiprankstipranks
Medicus Pharma Ltd (MDCX)
NASDAQ:MDCX
US Market
MDCX
Medicus Pharma Ltd
RESEARCH TOOLSreports

Medicus Pharma Ltd (MDCX) Stock News & Sentiment

241 Followers
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
Premium
Company Announcements
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
7d ago
MDCX
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
Premium
Company Announcements
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
12d ago
MDCX
Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate
Premium
Company Announcements
Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate
14d ago
MDCX
Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2
Premium
Company Announcements
Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2
14d ago
MDCX
Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan
Premium
Company Announcements
Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan
18d ago
MDCX
Medicus Pharma Advances SkinJect and Teverelix Pipelines, Adds AI to Clinical Strategy
Premium
Company Announcements
Medicus Pharma Advances SkinJect and Teverelix Pipelines, Adds AI to Clinical Strategy
19d ago
MDCX
Medicus Pharma Showcases Strong Phase 2 SkinJect Data Ahead of Fireside Chat
Premium
Company Announcements
Medicus Pharma Showcases Strong Phase 2 SkinJect Data Ahead of Fireside Chat
26d ago
MDCX
More MDCX News >

MDCX News on the Web

Medicus Pharma gives Teverelix Phase 2 FDA update – ICYMI
Proactive Investors
Bullish
Medicus Pharma enters media partnership with New to The Street
TipRanks News
Neutral
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
TipRanks News
Bearish
Medicus Pharma Advances Teverelix With Optimized Phase 2 Protocol Submission To FDA
rttnews
Bullish
Medicus Pharma submits optimized Phase 2 Teverelix trial protocol to FDA
Proactive Investors
Bullish
Medicus Pharma submits clinical study design to FDA for Teverelix
TipRanks News
Neutral
Medicus Pharma SkinJect Phase 2 study data endorsed by independent expert - ICYMI
Proactive Investors
Bullish
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
MDCX
Sector Average
Media Buzz
This Week2 articles
Weekly Average5 articles
News Sentiment
This Week100%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MDCX’s Media Buzz Sentiment?
2 articles about MDCX were published this week. In an average week, 5 articles are published.
    What is MDCX’s weekly average amount of articles?
    In an average week, 5 articles about MDCX are published.
      What is MDCX’s News Sentiment?
      100% of articles about MDCX were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        SLPSimulations Plus
        REPLReplimune Group
        Showing the stocks with the most bullish news sentiment over the past week